Distribution of active mRNA clinical trials worldwide 2022, by disease
As of August 2022, around 61 percent of all active mRNA vaccine clinical trials worldwide were for coronavirus treatment. This statistic displays the distribution of active mRNA vaccine clinical trials worldwide, by disease group.